Wikidata

(Q63338647)

English

Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events)

clinical trial

In more languages
default for all languages
No label defined

No description defined

Statements

short name
CANTOS (English)
0 references
title
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Quarterly Subcutaneous Canakinumab in the Prevention of Recurrent Cardiovascular Events Among Stable Post-myocardial Infarction Patients With Elevated hsCRP (English)
0 references
sponsor
Novartis
0 references
country
Argentina
0 references
Australia
0 references
Austria
0 references
Belgium
0 references
Brazil
0 references
Bulgaria
0 references
Canada
0 references
Colombia
0 references
Croatia
0 references
Estonia
0 references
Germany
0 references
Greece
0 references
Guatemala
0 references
Hungary
0 references
Iceland
0 references
India
0 references
Italy
0 references
Japan
0 references
Latvia
0 references
Lithuania
0 references
Mexico
0 references
Netherlands
0 references
Norway
0 references
Peru
0 references
Poland
0 references
Romania
0 references
Serbia
0 references
Slovakia
0 references
Slovenia
0 references
South Africa
0 references
Sweden
0 references
Taiwan
0 references
Turkey
0 references
United Kingdom
0 references
start time
11 April 2011
0 references
end time
28 March 2017
0 references
number of participants
10,071
0 references
research site
Novartis
0 references
minimum age
18 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q63338647&oldid=2150907118"